| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.00071 | 1 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.00042 | 1 |